Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

CP-99,219 is a new fluoroquinolone that has excellent activity against gram-positive organisms including penicillin- and cephalosporin-resistant Streptococcus pneumoniae strains. In our well-established rabbit model of meningitis, we conducted experiments to determine the concentrations of CP-99,219...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	París, M M, Hickey, S M, Trujillo, M, Shelton, S, McCracken, G H
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162720/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574509/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1243
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!